Cargando…

The impact of a postoperative multimodal analgesia pathway on opioid use and outcomes after cardiothoracic surgery

OBJECTIVE: The Enhanced Recovery after Surgery Cardiac Society recommends using multimodal analgesia (MMA) for postoperative pain however, evidence-based guidelines have yet to be established. This study examines the impact of a standardized postoperative MMA pathway in reducing opioid consumption a...

Descripción completa

Detalles Bibliográficos
Autores principales: Ward, Ceressa T., Moll, Vanessa, Boorman, David W., Ooroth, Lijo, Groff, Robert F., Gillingham, Trent D., Pyronneau, Laura, Prabhakar, Amit
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9801617/
https://www.ncbi.nlm.nih.gov/pubmed/36581941
http://dx.doi.org/10.1186/s13019-022-02067-3
_version_ 1784861528232558592
author Ward, Ceressa T.
Moll, Vanessa
Boorman, David W.
Ooroth, Lijo
Groff, Robert F.
Gillingham, Trent D.
Pyronneau, Laura
Prabhakar, Amit
author_facet Ward, Ceressa T.
Moll, Vanessa
Boorman, David W.
Ooroth, Lijo
Groff, Robert F.
Gillingham, Trent D.
Pyronneau, Laura
Prabhakar, Amit
author_sort Ward, Ceressa T.
collection PubMed
description OBJECTIVE: The Enhanced Recovery after Surgery Cardiac Society recommends using multimodal analgesia (MMA) for postoperative pain however, evidence-based guidelines have yet to be established. This study examines the impact of a standardized postoperative MMA pathway in reducing opioid consumption and related complications after cardiothoracic surgery (CTS). METHODS: Within a multicenter healthcare system, a postoperative MMA pathway was developed and implemented at two CTS intensive care units (ICU) while the other CTS ICU opted to maintain the existing opioid-based pathway. A retrospective chart review was conducted on patients admitted to a CTS ICU within this healthcare system after conventional coronary artery bypass grafting and/or valve surgery from September 1, 2018, to June 30, 2019. Comparative analysis was conducted on patients prescribed MMA versus those managed with an opioid-based pathway. The primary outcome was total opioid consumption, converted to morphine milligram equivalents, 72-h post-surgery. Secondary outcomes included mobility within one-day post-surgery, ICU length of stay (LOS), time to first bowel movement (BM), and time to first zero Richmond Agitation-Sedation Scale (RASS). RESULTS: Seven hundred sixty-two adults were included for final analysis. The MMA group had a higher body mass index, higher percentage of females, were more likely classified as African American and had higher scores for risk-adjusted complications. General Linear Model analysis revealed higher opioid consumption in the MMA group (Est. 0.22, p < 0.0009); however, this was not statistically significant after adjusting for differences in fentanyl usage. The MMA group was more likely to have mobility within one-day post-surgery (OR 0.44, p < 0.0001), have longer time to first BM (OR 1.93, p = 0.0011), and longer time to first zero RASS (OR 1.62, p = 0.0071). The analgesia groups were not a predictor for ICU LOS. CONCLUSIONS: Opioid consumption was not reduced secondary to this postoperative MMA pathway. The MMA group was more likely to have mobility within one-day post-surgery. Patients in the MMA group were also more likely to have prolonged time to first BM and first zero RASS. Development and evaluation of a perioperative MMA pathway should be considered. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13019-022-02067-3.
format Online
Article
Text
id pubmed-9801617
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-98016172022-12-31 The impact of a postoperative multimodal analgesia pathway on opioid use and outcomes after cardiothoracic surgery Ward, Ceressa T. Moll, Vanessa Boorman, David W. Ooroth, Lijo Groff, Robert F. Gillingham, Trent D. Pyronneau, Laura Prabhakar, Amit J Cardiothorac Surg Research OBJECTIVE: The Enhanced Recovery after Surgery Cardiac Society recommends using multimodal analgesia (MMA) for postoperative pain however, evidence-based guidelines have yet to be established. This study examines the impact of a standardized postoperative MMA pathway in reducing opioid consumption and related complications after cardiothoracic surgery (CTS). METHODS: Within a multicenter healthcare system, a postoperative MMA pathway was developed and implemented at two CTS intensive care units (ICU) while the other CTS ICU opted to maintain the existing opioid-based pathway. A retrospective chart review was conducted on patients admitted to a CTS ICU within this healthcare system after conventional coronary artery bypass grafting and/or valve surgery from September 1, 2018, to June 30, 2019. Comparative analysis was conducted on patients prescribed MMA versus those managed with an opioid-based pathway. The primary outcome was total opioid consumption, converted to morphine milligram equivalents, 72-h post-surgery. Secondary outcomes included mobility within one-day post-surgery, ICU length of stay (LOS), time to first bowel movement (BM), and time to first zero Richmond Agitation-Sedation Scale (RASS). RESULTS: Seven hundred sixty-two adults were included for final analysis. The MMA group had a higher body mass index, higher percentage of females, were more likely classified as African American and had higher scores for risk-adjusted complications. General Linear Model analysis revealed higher opioid consumption in the MMA group (Est. 0.22, p < 0.0009); however, this was not statistically significant after adjusting for differences in fentanyl usage. The MMA group was more likely to have mobility within one-day post-surgery (OR 0.44, p < 0.0001), have longer time to first BM (OR 1.93, p = 0.0011), and longer time to first zero RASS (OR 1.62, p = 0.0071). The analgesia groups were not a predictor for ICU LOS. CONCLUSIONS: Opioid consumption was not reduced secondary to this postoperative MMA pathway. The MMA group was more likely to have mobility within one-day post-surgery. Patients in the MMA group were also more likely to have prolonged time to first BM and first zero RASS. Development and evaluation of a perioperative MMA pathway should be considered. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13019-022-02067-3. BioMed Central 2022-12-30 /pmc/articles/PMC9801617/ /pubmed/36581941 http://dx.doi.org/10.1186/s13019-022-02067-3 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Ward, Ceressa T.
Moll, Vanessa
Boorman, David W.
Ooroth, Lijo
Groff, Robert F.
Gillingham, Trent D.
Pyronneau, Laura
Prabhakar, Amit
The impact of a postoperative multimodal analgesia pathway on opioid use and outcomes after cardiothoracic surgery
title The impact of a postoperative multimodal analgesia pathway on opioid use and outcomes after cardiothoracic surgery
title_full The impact of a postoperative multimodal analgesia pathway on opioid use and outcomes after cardiothoracic surgery
title_fullStr The impact of a postoperative multimodal analgesia pathway on opioid use and outcomes after cardiothoracic surgery
title_full_unstemmed The impact of a postoperative multimodal analgesia pathway on opioid use and outcomes after cardiothoracic surgery
title_short The impact of a postoperative multimodal analgesia pathway on opioid use and outcomes after cardiothoracic surgery
title_sort impact of a postoperative multimodal analgesia pathway on opioid use and outcomes after cardiothoracic surgery
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9801617/
https://www.ncbi.nlm.nih.gov/pubmed/36581941
http://dx.doi.org/10.1186/s13019-022-02067-3
work_keys_str_mv AT wardceressat theimpactofapostoperativemultimodalanalgesiapathwayonopioiduseandoutcomesaftercardiothoracicsurgery
AT mollvanessa theimpactofapostoperativemultimodalanalgesiapathwayonopioiduseandoutcomesaftercardiothoracicsurgery
AT boormandavidw theimpactofapostoperativemultimodalanalgesiapathwayonopioiduseandoutcomesaftercardiothoracicsurgery
AT oorothlijo theimpactofapostoperativemultimodalanalgesiapathwayonopioiduseandoutcomesaftercardiothoracicsurgery
AT groffrobertf theimpactofapostoperativemultimodalanalgesiapathwayonopioiduseandoutcomesaftercardiothoracicsurgery
AT gillinghamtrentd theimpactofapostoperativemultimodalanalgesiapathwayonopioiduseandoutcomesaftercardiothoracicsurgery
AT pyronneaulaura theimpactofapostoperativemultimodalanalgesiapathwayonopioiduseandoutcomesaftercardiothoracicsurgery
AT prabhakaramit theimpactofapostoperativemultimodalanalgesiapathwayonopioiduseandoutcomesaftercardiothoracicsurgery
AT wardceressat impactofapostoperativemultimodalanalgesiapathwayonopioiduseandoutcomesaftercardiothoracicsurgery
AT mollvanessa impactofapostoperativemultimodalanalgesiapathwayonopioiduseandoutcomesaftercardiothoracicsurgery
AT boormandavidw impactofapostoperativemultimodalanalgesiapathwayonopioiduseandoutcomesaftercardiothoracicsurgery
AT oorothlijo impactofapostoperativemultimodalanalgesiapathwayonopioiduseandoutcomesaftercardiothoracicsurgery
AT groffrobertf impactofapostoperativemultimodalanalgesiapathwayonopioiduseandoutcomesaftercardiothoracicsurgery
AT gillinghamtrentd impactofapostoperativemultimodalanalgesiapathwayonopioiduseandoutcomesaftercardiothoracicsurgery
AT pyronneaulaura impactofapostoperativemultimodalanalgesiapathwayonopioiduseandoutcomesaftercardiothoracicsurgery
AT prabhakaramit impactofapostoperativemultimodalanalgesiapathwayonopioiduseandoutcomesaftercardiothoracicsurgery